The use of new procoagulants in blunt and penetrating trauma

Current Opinion in Anaesthesiology
Maria Rita Peralta, Pratima Chowdary

Abstract

Uncontrolled bleeding in trauma secondary to a combination of surgical bleeding and trauma-induced complex coagulopathy is a leading cause of death. Prothrombin complex concentrates (PCCs), recombinant activated factor seven (rFVIIa) and recombinant human prothrombin act as procoagulants by increasing thrombin generation and fibrinogen concentrate aids stable clot formation. This review summarizes the current evidence for procoagulant use in the management of bleeding in trauma, and data and evidence gaps for routine clinical use. Retrospective and prospective studies of PCCs (±fibrinogen concentrate) have demonstrated a decreased time to correction of trauma coagulopathy and decreased red cell transfusion with no obvious effect on mortality or thromboembolic outcomes. PCCs in a porcine model of dilutional coagulopathy demonstrated a sustained increase in thrombin generation, unlike recombinant human prothrombin which showed a transient increase and has been studied only in animals. In other retrospective studies, there is a suggestion that lower doses of PCCs may be effective in the setting of acquired coagulopathy. There is increasing evidence that early correction of coagulopathy has survival benefits, and the use of procoag...Continue Reading

References

Mar 1, 1978·American Journal of Diseases of Children·R H Yolken, M W Hilgartner
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·F S HagenK Kurachi
Aug 1, 1982·The Journal of Trauma·J L KashukJ B Moore
Dec 10, 1999·Lancet·G KenetU Martinowitz
Jul 12, 2003·The Journal of Trauma·Jana B A MacLeodMary Murtha
Jan 18, 2006·British Journal of Haematology·T P BaglinUNKNOWN British Committee for Standards in Haematology
Jun 10, 2008·European Journal of Anaesthesiology·C M Samama
May 14, 2010·Cardiovascular Research·Bernhard F BeckerMatthias Jacob
Aug 12, 2010·The Journal of Trauma·Charles E WadeJohn B Holcomb
Mar 8, 2011·Critical Care : the Official Journal of the Critical Care Forum·Herbert SchöchlCristina Solomon
Apr 20, 2011·Annals of Internal Medicine·Veronica YankRandall S Stafford
Apr 12, 2012·The Journal of Trauma and Acute Care Surgery·Bellal JosephPeter Rhee
May 18, 2012·Transfusion·Suchitra Pandey, Girish N Vyas
Jul 11, 2014·Critical Care : the Official Journal of the Critical Care Forum·Herbert SchöchlChristoph J Schlimp
Feb 6, 2015·Anesthesiology·Oliver Grottke, Jerrold H Levy
Nov 26, 2015·Emergency Medicine Journal : EMJ·A KehoeF Lecky
Apr 14, 2016·Critical Care : the Official Journal of the Critical Care Forum·Rolf RossaintDonat R Spahn
Jul 19, 2016·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Kenny M HanssonAnn Lövgren
Dec 13, 2016·British Journal of Anaesthesia·J W Simmons, M F Powell
Jan 13, 2017·The British Journal of Surgery·K BalversUNKNOWN Targeted Action for Curing Trauma-Induced Coagulopathy (TACTIC) Collaborators
Feb 9, 2018·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Pratima ChowdaryRavi Gill
Apr 18, 2018·The Journal of Trauma and Acute Care Surgery·Faisal JehanBellal Joseph

❮ Previous
Next ❯

Citations

Jan 6, 2021·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·Vladimir ČernýHerbert Schöchl
Dec 4, 2020·Expert Review of Hematology·Lena M Napolitano
Mar 27, 2020·Military Medical Research·Henry T Peng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.